Quorum Health Corporation provided earnings guidance for the fourth quarter and year ended December 31, 2017. For the quarter, the company expects net loss of $26,023,000, EBITDA was $2,785,000, Adjusted EBITDA of $49,005,000, Adjusted EBITDA, adjusted for divestitures of $54,149,000, Adjusted EBITDA, adjusted for potential divestitures of $57,263,000. The company expects net operating revenues of approximately $515 million and net loss attributable to the company of approximately $27 million. For the year, the company expects net loss of $112,357,000, EBITDA of $70,010,000, Adjusted EBITDA of $141,845,000, Adjusted EBITDA, adjusted for divestitures of $162,482,000, Adjusted EBITDA, adjusted for potential divestitures of $170,819,000. The company expects net operating revenues of approximate $2.072 billion. Net loss attributable to the company for the year ended December 31, 2017 is expected to approximate $114 million.